Blog
Dotmatics Boosts Bioprocessing Presence with M-Star Acquisition
🔹 Dotmatics acquires M-Star to expand presence in bioprocessing, focusing on accelerated analysis capabilities and superior user experiences in fluid dynamics simulations. 🔸
Revolutionizing Biopharmaceutical Development: Mastering In-Process Monitoring
📰 Mastering In-Process Attribute Monitoring in Biopharmaceutical Development explores the importance of continuous monitoring and advanced technologies. 💡🧪📊🌐
Shocking FDA Investigation: Obesity Drugs Linked to Suicidal Thoughts
📢 FDA investigates suicide risk of obesity drugs semaglutide and tirzepatide, as well as hair loss and aspiration during surgery. Novo Nordisk and Eli Lilly cooperate.
Huge €410M Licensing Deal for Fibro-Inflammatory Disease Treatments
📣 Boehringer Ingelheim partners with Kyowa Kirin Co., Ltd. for €410m license deal to treat fibro-inflammatory diseases! 🧪💰
miRNA Specialist Resalis Therapeutics Raises €10m for Groundbreaking Obesity Treatment
💰 Italian biotech Resalis Therapeutics raises €10m in Series A funding for obesity treatment RES-010. 🍔💪📈
The Future of Cell and Gene Therapy: Groundbreaking Advancements and Promising Potential
📰 Discover the future of cell and gene therapy in 2024! Learn about advancements, challenges, and its potential impact! 🧬🔬🌟
Goldman Sachs Raises $650 Million for Life Sciences Investments: A Game-Changer for Medical Innovations
🏦 Goldman Sachs raises $650m for life sciences investments, showing growing interest in the sector. 💼🔬💰
Oligo Factory Achieves GMP Compliance: Exceptional Quality Control and Regulatory Standards
📢 Oligo Factory achieves GMP compliance! 🏭 CEO Chris Boggess celebrates the team's hard work in maintaining high-quality standards. 💼💯
Big Moves in Biotech: Veranova Beam and AAX
📰 Exciting changes ahead in the global biotech industry! Veranova, Beam, and AAX Biotech announce top-level team shuffles. Stay tuned! 🌍💼🔬
UK Accelerates Biologic Manufacturing with Next-Gen Therapies
📰 The U.K. is leading the way in biologic manufacturing, investing in cutting-edge therapies and advanced analytical technologies. 🇬🇧💉
